HomeBUSINESS
BUSINESS

SI-613 Enters PIIb Study for Enthesopathy: Ono, Seikagaku
(Oct.3.2017)

Ono Pharmaceutical and Seikagaku said on September 28 that they have commenced a PIIb clinical study of SI-613 for the treatment of enthesopathy in Japan ...
(LOG IN FOR FULL STORY)

News Calendar